ZOM Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 16:00):

Stats
Today's Volume	1.33M
Average Volume	4.79M
Market Cap	127.49M
EPS	$0 ( 2024-03-20 )
Next earnings date	( $0 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-4.34
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2023-12-15	Powers Johnny D	Buy	100 000	Common Stock, without par value
2023-12-15	Powers Johnny D	Buy	100 000	Common Stock, without par value
2023-11-17	Powers Johnny D	Buy	100 000	Common Stock, without par value
2023-11-17	Heaton Larry C Ii	Buy	100 000	Common Stock, without par value
2023-11-15	Powers Johnny D	Buy	150 000	Common Stock, without par value

INSIDER POWER
93.88
Last 93 transactions
Buy: 92 487 495 \| Sell: 14 772 509

Volume Correlation

Long: -0.12 (neutral)

Short: -0.94 (very strong negative)

Signal:(40.05) Neutral

Zomedica Pharmaceuticals Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Zomedica Pharmaceuticals Correlation - Currency/Commodity

0.00
( neutral )

Zomedica Pharmaceuticals Financials

Annual	2024
Revenue:	$25.19M
Gross Profit:	$17.32M (68.76 %)
EPS:	$-0.0352

Q4	2024
Revenue:	$7.34M
Gross Profit:	$3.20M (43.66 %)
EPS:	$-0.0229

Q3	2024
Revenue:	$6.35M
Gross Profit:	$4.36M (68.73 %)
EPS:	$-0.000500

Q2	2024
Revenue:	$6.02M
Gross Profit:	$4.05M (67.24 %)
EPS:	$-0.00540

Financial Reports:

No articles found.

Zomedica Pharmaceuticals

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment of various musculoskeletal issues, such as broken bones, tendonitis, and torn ligaments in horses and small animals. It has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for development and markets a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. was founded in 2015 and is headquartered in Ann Arbor, Michigan.